Pitfalls of PD-L1 Immunohistochemistry: A Comparison of 22C3 and SP263 antibodies Across Laboratories and Pathologists

被引：0
|
作者：
Wilberger, Adam [1 ]
Aisner, Dara
Merrick, Daniel T. [2 ]
机构：
[1] Univ Colorado Hosp, Aurora, CO USA
[2] Univ Colorado, Boulder, CO 80309 USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2118
引用
收藏
页码：756 / 757
页数：2
相关论文
共 50 条
  • [31] Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
    Zhou, Caicun
    Srivastava, Minu K.
    Xu, Hao
    Felip, Enriqueta
    Wakelee, Heather
    Altorki, Nasser
    Reck, Martin
    Liersch, Rudiger
    Kryzhanivska, Anna
    Oizumi, Satoshi
    Tanaka, Hiroshi
    Hamm, John
    McCune, Steven L.
    Bennett, Elizabeth
    Gitlitz, Barbara
    McNally, Virginia
    Ballinger, Marcus
    McCleland, Mark
    Zou, Wei
    Das Thakur, Meghna
    Novello, Silvia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [32] A multicentric Portuguese study for the assessment of PD-L1 score in NSCLC using 22C3 and SP263 clones on Ventana's platform: a stepping stone for the IVDR legislation landscape?
    Sousa, V.
    Luis, A.
    Ribeiro, A.
    Souto de Moura, C.
    Rolim, I.
    Cunha, A. L.
    Quintana, C.
    Eloy, C.
    Pinto, E.
    Cunha, F.
    Correia-Pinto, J.
    Carvalho, L.
    Vizcaino, J.
    Coelho, C.
    Ferreira Carlos, F.
    Borralho, P.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S152 - S153
  • [33] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
    Chauhan, Aastha
    Racila, Emilian
    Stewart, Jimmie
    Amin, Khalid
    LABORATORY INVESTIGATION, 2019, 99
  • [34] Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263
    Loghin, Andrada
    Nechifor-Boila, Adela
    Borda, Angela
    Nechifor-Boila, Ioan Alin
    Voidazan, Septimiu
    Decaussin-Petrucci, Myriam
    VIRCHOWS ARCHIV, 2022, 480 (02) : 303 - 313
  • [35] Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263
    Andrada Loghin
    Adela Nechifor-Boilă
    Angela Borda
    Ioan Alin Nechifor-Boilă
    Septimiu Voidazan
    Myriam Decaussin-Petrucci
    Virchows Archiv, 2022, 480 : 303 - 313
  • [36] 抗体22C3与SP263检测非小细胞肺癌标本PD-L1水平的一致性比较
    王葆强
    邵琼怡
    孙波
    中国民康医学, 2023, 35 (04) : 138 - 140
  • [37] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
    Chauhan, Aastha
    Racila, Emilian
    Stewart, Jimmie
    Amin, Khalid
    MODERN PATHOLOGY, 2019, 32
  • [38] Precision and Repeatability of the VENTANA PD-L1 (SP263) Assay Across Six Different Tumor Types
    Nielsen, Alma
    Manriquez, Guadalupe
    Hayden, Dorothy
    Lian, Fangru
    Liu, Chunyan
    Patil, Pallavi
    Wang, Peiyi
    Gu, Pengfei
    Schnittker, Karina
    Roland, Bryan
    Quiroz, Michelle
    Newell, Amy Hanlon
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 830 - 831
  • [39] Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study
    Herbst, R. S.
    de Marinis, F.
    Giaccone, G.
    Reinmuth, N.
    Vergnenegre, A.
    Barrios, C. H.
    Morise, M.
    Felip, E.
    Andric, Z.
    Geater, S.
    Ozguroglu, M.
    Mocci, S.
    McCleland, M.
    Zou, W.
    Enquist, I.
    Komatsubara, K.
    Deng, Y.
    Kuriki, H.
    Spigel, D. R.
    Jassem, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 62 - 63
  • [40] Precision and Repeatability of the VENTANA PD-L1 (SP263) Assay Across Six Different Tumor Types
    Nielsen, Alma
    Manriquez, Guadalupe
    Hayden, Dorothy
    Lian, Fangru
    Liu, Chunyan
    Patil, Pallavi
    Wang, Peiyi
    Gu, Pengfei
    Schnittker, Karina
    Roland, Bryan
    Quiroz, Michelle
    Newell, Amy Hanlon
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 830 - 831
12345